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http:WHAT THIS PAPER ADDS
A local skin ﬂap may be appropriate for treatment of skin necrosis complicating a haemodialysis angioaccess that
is associated with bleedingda potentially lethal complication. Two recent series reported a total of 188 deaths
by exsanguination. However, there is only one recent report of the various therapeutic options to be used in
such cases. We therefore reviewed our series of end-stage renal disease patients who were treated by per-
forming a locally rotated Limberg skin ﬂap for angioaccess ulceration and bleeding.Objective: To assess the efﬁcacy of a Limberg skin ﬂap to treat non-infected necrosis and bleeding at angioaccess
puncture sites.
Methods: Retrospective analysis of 40 selected (no infection, necrosis <20 mm diameter) patients (25
arteriovenous ﬁstulae [AVF], 15 grafts) treated between 1998 and 2012 by rhomboid excision, vessel repair, and a
locally rotated full-thickness Limberg skin ﬂap together with early postoperative percutaneous transluminal
angioplasty (PTA; n ¼ 23/40). Success was deﬁned as wound healing and angioaccess patency without
complications.
Results: Success rates at 1 and 6 months were 96% (24/25) and 76% (19/25), respectively, for AVF, and 80%
(12/15) and 40% (6/15) for arteriovenous grafts. Complications included ﬂap necrosis (n ¼ 2), graft thrombosis
(n ¼ 4), minor sepsis (n ¼ 1), death (n ¼ 2), and new puncture site necrosis (n ¼ 3). Four patients were lost to
follow-up.
Conclusions: Vessel or graft repair, PTA for distal stenoses and local debridement followed by a Limberg skin ﬂap
for tissue defects prevented further bleeding and maintained vascular access patency in 25/40 (62%) patients.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Combining rhomboid excision and a locally rotated full-
thickness skin ﬂap was described for treatment of skin
lesions by Limberg in 1946.1 This technique may be
appropriate for the treatment of necrosis associated with
bleeding complicating a haemodialysis angioaccess, a
potentially lethal complication. Two recent series2,3 re-
ported a total of 188 deaths by exsanguination. However,
there is only one recent report4 of the various therapeutic
options to be used in such cases, from access ligation to
conservative surgical treatment with elliptical excision of
the ulcer and vessel repair associated either with direct skin
suture or with skin advancement ﬂap. We therefore
reviewed our series of end-stage renal disease (ESRD) pa-
tients who, in the absence of clinical infection, were treatedrresponding author. P. Bourquelot, Clinique Jouvenet, 6 Square
et, 75016 Paris, France.
il address: pbourquelot@sfav.org (P. Bourquelot).
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//dx.doi.org/10.1016/j.ejvs.2013.05.021by performing a locally rotated Limberg skin ﬂap for
angioaccess ulceration and bleeding, frequently combined
with percutaneous transluminal angioplasty (PTA) for
downstream stenosis.PATIENTS AND METHODS
This retrospective analysis included 40 selected patients
with clean skin necrosis and bleeding at arteriovenous
angioaccess haemodialysis puncture sites treated with a
Limberg skin ﬂap (Fig. 1) from January 1998 to June 2012 at
two institutions. The selection criteria for autologous ac-
cesses and also for grafts included the absence of clinical
infection (fever, local inﬂammation  serous or purulent
discharge) and necrosis of less than 20 mm in diameter.
Twenty-ﬁve patients had an autologous arteriovenous ﬁs-
tula (AVF) and 15 had a graft. All accesses were located in
the upper extremity, except for one femoral vein super-
ﬁcialisation (Table 1). The degree of haemorrhaging ranged
from prolonged bleeding time after needle withdrawal at
the end of a haemodialysis session (n ¼ 18) to recurrent
bleeding at home (n ¼ 15) or major bleeding requiring
Figure 1. Limberg ﬂap after rhomboid excision of necrosis, and
diagram of the conduit (modiﬁed from Germann5).
Table 2. Patient characteristics.
Number of patients 40
Male 19 (48%)
Age
mean  SD
(range)
65 years  16 (4e85)
BMI
mean  SD
(range)
23.2  4.1 (16.6e40.2)
Diabetes 8 (5%)
Previous AVF
mean  SD (range)
2.5  1.9 (0e10)
Angioaccess AVF: 25 (8 superﬁcializations)
Graft: 15
Previous PTA  stent 24 patients (55%)
Duration of dialysis,
mean  SD (range)
9 years  8 (1e34)
Age of access,
mean  SD (range)
5.3 years  4.4 (0.8e22)
Previous kidney
transplantation
One: 5 patients; two: 3
patients; three: 1 patient
Diameter of necrosis,
mean  SD (range)
7.4 mm  4.7 (3e20)
Note. BMI ¼ body mass index;
AVF ¼ arteriovenous ﬁstula;
PTA ¼ percutaneous transluminal angioplasty.
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listed in Table 2. The pre-cannulation skin cleansing protocol
varied from chlorhexidineealcohol to povidoneeiodine
according to the protocols of the different dialysis centres.
The rope ladder cannulation technique (rotating cannula-
tion sites) with frequent inappropriate puncture rotation
had been used in all but two patients for whom the
buttonhole technique was used (same-site cannulation).
Post-cannulation false aneurysm was associated with ne-
crosis and bleeding at the puncture site (Fig. 2) in sevenTable 1. Types of vascular access and locations.
Autologous AVF (n ¼ 25)
Radiocephalic 13
Ulnocephalic 1
Brachiocephalic 7
Brachiobasilic 3
Femorofemoral 1
Graft (n ¼ 15)
Radiocephalic 6
Brachioaxillary 9
Note. AVF ¼ arteriovenous ﬁstula.patients. Mild aneurysmal dilatation of the access was
present in 29 patients, requiring no speciﬁc or urgent
treatment.
Percutaneous treatment of the downﬂow stenosis pre-
sent in 23/40 (58%) patients (11/25 AVF, 12/15 grafts) was
performed within 1 week of surgery.Figure 2. Excision of necrosis associated with pseudoaneurysm and
incisions for creating the ﬂap.
Table 3. Necrosis at haemodialysis arteriovenous ﬁstula (AVF)/
graft puncture site: complications and success rates.
AVF Graft
Limberg ﬂap for necrosis
(40 patients)
25 15
Associated non-occlusive
down ﬂow stenosis:
11 (44%) 13 (86%)
Treated at surgery 1
Treated by PTA
(within 1 week
postoperatively)
11 12
Early complications
(1 month)
Local complication
Flap necrosis
(access ligation)
1 1
Minimal infection
treated by antibiotics
1
Access occlusion
Successful percutaneous
de-obstruction
1b
Unsuccessful
percutaneous
de-obstruction
1b
Successa at 1 month 24/25 (96%) 12/15 (80%)
Late complications
(from 2 to 6 months)
Unrelated death 1 1
Lost to follow-up 2 2
Necrosis at new site
(access ligation)
2 1
Access occlusion
(neglected)
2
Successa at 6 months 19/25 (76%) 6/15 (40%)
Note. PTA ¼ percutaneous transluminal angioplasty.
a Access patency and ﬂap cicatrisation, with no associated
complications.
b No early postoperative PTA.
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Brieﬂy, the outline of the necrosis excision is drawn on
the skin (Fig. 1), providing an equilateral diamond-shaped
skin area with angles of 60 and 120, and a short diago-
nal perpendicular to the vein/graft direction. When
designing the ﬂap, the short diagonal is extended in one
direction by its own length and a further incision is drawn
parallel to the side of the rhombus. All incisions are equal in
length to the short axis of the rhombus. Echo-guided
locoregional anaesthesia sometimes combined with seda-
tion and perioperative broad spectrum antibiotic treatment
are provided. Primary vascular control is mandatory to limit
the risk of major intraoperative bleeding.
Preventive haemostasis6 was therefore used in 18 of 40
patients who presented with necrotic lesions situated at or
below the mid part of the upper arm. Upper limb exsan-
guination was achieved ﬁrst by application of an elastic
Esmarch bandage, and then by a pneumatic tourniquet
placed high on the upper arm and which was inﬂated above
systolic arterial pressure. In 22 patients with more proximal
lesions, vascular control was obtained by applying clamps
via separate incisions proximal and distal to the ulcerated
area. Excision of the necrotic tissues was performed care-
fully to avoid damaging the underlying vein/graft. The
anterior defect of the vessel wall was closed by interrupted
prolene sutures in all but two patients. However, a large
defect of the vessel wall required vein patching for one graft
and resection with an end to-end anastomosis was neces-
sary for one ﬁstula. The local full-thickness skin ﬂap was
then raised, rotated overlying the vein/graft and sutured in
place with monoﬁlament interrupted sutures. The donor
site was closed similarly. Finally, the tourniquet was
released after application of dressings, and access patency
was checked using a sterile Doppler probe. Haemodialysis
was continued by puncture of other portions of the access
during healing of the ﬂap. Non-occlusive downstream
venous stenosis was associated in 11/25 ﬁstulae (44%) and
in 13/15 grafts (86%). This stenosis was treated by surgical
repair of the venous anastomosis in one patient, and by PTA
within 1 week postoperatively in 23 patients. This correction
of down-ﬂow stenosis was considered to be essential in
order to decrease the pressure inside the vein/graft and the
tension on the sutures, with the potential for secondary
bleeding and necrosis, and to limit the risk of postoperative
occlusion of the access.
All patients were followed up by the surgeon with duplex
examination at 1 and 6 months. Success was deﬁned as
both wound healing and patency of the angioaccess without
postoperative complications or new treatment (1 week
postoperative-associated PTA excluded). Death and loss to
follow-up were considered as complications.RESULTS
The early complications for autologous AVF necrosis 1
month postoperatively included one minor superﬁcial ﬂap
infection treated with antibiotics and one skin ﬂap necrosis
treated by access ligation (see Table 3). Success with nomajor associated complications was thus achieved at 1
month in 24/25 patients (96%) who presented healing of
the ﬂap and maintained access patency. From 2 to 6
months, the complications observed were two cases of
recurrence of necrosis at a different ﬁstula site, which
required ligation, two patients lost to follow-up and one
unrelated death. Cicatrisation and patency without com-
plications at 6 months were achieved in 19/25 patients
(76%) (see Table 3).
The early complications for graft angioaccess necrosis 1
month postoperatively included one case of ﬂap necrosis
requiring graft removal and two cases of graft occlusion
related to severe stenosis of the venous anastomosis in
patients who had had no PTA soon after construction of the
ﬂap. Success with no associated complications was thus
observed in 12/15 patients (80%). Late complications
included one case of necrosis at a new site treated by
graft ligation, two neglected graft occlusions related to
386 European Journal of Vascular and Endovascular Surgery Volume 46 Issue 3 September/2013recurrence of downﬂow stenosis, two patients lost to
follow-up, and one unrelated death. Finally, graft patency
with no complications at 6 months was achieved in 6/15
patients (40%) (see Table 3).DISCUSSION
Necrosis and bleeding are usually a consequence of
repeated cannulation in a single limited area of the arte-
riovenous angioaccess. This causes thinning and fragilisation
of the skin, the subcutaneous tissue, and the underlying
anterior vessel wall. Increased pressure inside the access
and aneurysmal dilatation of the vein may also be involved,
often related to downstream stenosis. Previous surgical
superﬁcialisation of the vein, as well as the development of
a false aneurysm (Fig. 2) at a puncture site may also play a
role, especially in grafts. In this setting, major bleeding is
often prevented temporarily by a thrombus adhering to the
ulcer, which can easily be dislodged, leading to major hae-
morrhage. Emergency treatment by immediate ﬁnger
compression, tourniquet placement, or occasionally by
temporary skin suturing is required to prevent exsangui-
nation. In all cases, urgent transfer to a surgical facility is
mandatory.
Necrosis should be prevented by appropriate needle
rotation, when the rope ladder cannulation technique is
used, and by surveillance of vein dilatation and timely
surgical reduction or access ligation of major aneurysmal
dilatation. Prevention of bleeding also includes surgical
treatment of false aneurysms at needle stick sites, and
timely treatment of downstream vein stenoses by PTA is
essential. The buttonhole cannulation technique might also
provide effective prevention, especially when the usable
length of the AVF is limited. This “constant site cannulation”
method avoids repeated punctures in a small area, which
might fragilise the skin and the vein.
However, despite careful cannulation techniques, major
bleedingdpotentially resulting in exsanguination and
deathdhas been reported to be the consequence of ne-
crosis at haemodialysis access puncture sites. The ﬁrst
report of a series of fatal vascular access haemorrhages
among haemodialysis patients was published in 2007 by
Byard.7 In 2011, Gill et al.2 reviewed “unexpected, violent,
and suspicious deaths” reported in New York City between
January 2003 and August 2011. One hundred deaths due to
haemorrhage from a haemodialysis arteriovenous angioac-
cess were identiﬁed. The majority (81%) of these fatal ex-
sanguinations occurred at home. In 2012, Ellingson et al.3
reported a similar series, with 88 deaths in patients
treated at 58 different dialysis facilities in the District of
Columbia, and the states of Maryland and Virginia. While
haemorrhage appeared to be a relatively rare cause of
death (0.4% of all ESRD deaths), it accounted for more than
1,600 deaths in the USA from 2000 to 2006 according to the
reports made by the haemodialysis providers to the Centers
for Medicare and Medicaid Services. Moreover, a regional
investigation conducted by Ellingson et al.3 suggested that
these national ﬁgures were potentially underestimatedowing to major under-reporting of fatal haemorrhages.
Finally, of 24 patients with ulcerated lesions retrospectively
identiﬁed by Jaffers and Fasola,4 two patients died from a
major haemorrhagic event before surgical consultation.
It is essential to treat necrosis as soon as it is diagnosed
by clinical examination to prevent major bleeding. Surgery
is mandatory and urgent, although antibiotic treatment and
medical surveillance or isolated PTA have been reported to
be successful in some unpublished individual cases with
limited areas of skin necrosis. The surgical techniques re-
ported for conservative treatment of necrosis at haemo-
dialysis puncture sites include ﬁstula ligation; by-pass graft;
direct suture; skin mobilisation and suture, possibly com-
bined with aneurysm reduction; and skin ﬂap transposition.
From our previous experience, we consider that ﬁstula
ligation/excision is mandatory when necrosis is more than
20 mm in diameter and when it is associated with other
major angioaccess complications, including infection,
downstream stenosis resistant to PTA, and high-grade
venous aneurysm. In this setting, infection (especially for
polytetraﬂuoroethylene [PTFE] angioaccesses) is a contra-
indication for conservative treatment as by-pass grafting
close to the infection site is not always a safe option. Even
in the absence of infection, direct repair would result in
repeated necrosis and bleeding owing to the fragility of the
tissues surrounding the ulcer and the tension on the su-
tures. If the necrosis area is limited, minimal skin mobi-
lisation and suturing or advancement ﬂap have been
reported to be successful after ulcer excision and vessel wall
suturing.4 For larger ulcerated areas, a locally rotated full-
thickness skin ﬂap might be the best option. In 1946, Lim-
berg described a standardised locally rotated ﬂap with 60
and 120 angles for primary closure of rhomboid defects
after excision of skin lesions. In 1972, Lister1 reported
excellent results using this technique for plastic surgery in
more than 50 patients, and claimed safety, reliability, and
versatility. Furthermore, he emphasised the geometrically
precise design and the fact that only one measurement
(length of the short diagonal) was needed to delineate the
defect and construct the ﬂap. Cases of successful locally
rotated ﬂaps were ﬁrst reported for PTFE angioaccess skin
necrosis by Moosa et al.8 in 1985 and by Tellis et al.9 in
1989. Since the latter publication, we have routinely used
Limberg skin ﬂaps for the treatment of necrosis overlying
both autologous and graft angioaccess if the necrosis is
<20 mm diameter and there is no clinically obvious infec-
tion. Further PTA to correct a downstream venous stenosis
is always performed within 1 week of surgery. We use this
technique even for “clean” exposed PTFE, in preference to
segmental graft explantation and re-routing, which is a
more extensive procedure.
There are only a few previous publications concerning
angioaccess necrosis and bleeding, and they mostly report
individual cases. Jaffers and Fasola4 recently reported a
series of 24 patients with previous spontaneous bleeding
from ulceration, gathered over a 10-year period: two pa-
tients died of major haemorrhage before being treated, and
one patient with two simultaneous ulcers was treated by
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suturing of the ulcer could not maintain haemostasis in
three out of four patients. Surgical excision of the ulcer with
primary closure was used in most cases, but a second sur-
gical procedure for a new onset of bleeding or necrosis was
necessary for seven patients. From our earlier experience,
elliptical excision followed by direct skin suture or
advancement ﬂap (the techniques mostly used by Jaffers
and Fasola4) should be applied only when the area of ne-
crosis is limited.
In the retrospective study reported here, 40 patients (25
AVF and 15 grafts) presenting skin necrosis at the puncture
site were treated by a Limberg rotated full-thickness ﬂap.
The results were considered favourable as only two patients
experienced subsequent skin suture necrosis or infection
requiring access ligation, and one patient presented with
permanent graft thrombosis. Moreover, angioaccess
patency was maintained in all the remaining 37 patients,
allowing postoperative haemodialysis and thus avoiding the
need for a central vein dialysis catheter. It must be
emphasised that immediate success rates were similar in
both populations. After 6 months, without further surgery
or PTA, patency rates were higher for autologous accesses,
as expected. We recognise the limitations of this retro-
spective study with a fairly small number of patients and
mid-term follow-up. Nevertheless, we believe that this
technique is a valuable tool for vascular surgeons working
with haemodialysis angioaccesses.
CONCLUSION
The treatment of necrosis and bleeding at angioaccess
puncture sites is a surgical emergency to prevent further
possibly fatal bleeding. When no infection is present a full-
thickness rotated Limberg skin ﬂap may be used safely,
combined, when needed, with PTA to correct any down-
stream stenosis. High rates of primary ﬂap cicatrisation and
preservation of patency can be achieved in both AVF andgrafts. Longer-term patency rates were higher for autolo-
gous accesses.FUNDING
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